Evaluation of the Clinical Efficacy of Blood and Blood Component Use in the Treatment of Burn-Related Anemia

Objective: To analyze the efficacy and appropriateness of using blood and its components in the treatment of anemia in patients with burn disease.

Materials and methods: In the Department of Combustiology at the Samarkand Branch of the Republican Research Centre of Emergency Medicine, from 2020 to 2025, the treatment outcomes of 920 patients with severe burn injuries were analyzed. The patients were divided into two groups.

The main group included 570 (61.9%) patients with severe and extremely severe burns. Treatment of burn-related anemia was carried out with consideration of its etiopathogenesis. It included individualized infusion-transfusion therapy, minimization of wound blood loss, as well as plasma transfusions, blood transfusion, and administration of 5%, 10%, and 20% albumin solutions according to clinical and laboratory indicators.

The control group consisted of 350 (38.04%) patients with severe and extremely severe burns. They received infusion-transfusion therapy according to the standard protocol. The patients’ age ranged from 6 months to 76 years.

Results: Timely treatment of burn-related anemia, as a severe complication was based on the clinical course of the disease and laboratory blood parameters. An individualized approach to transfusion therapy included: early administration of plasma transfusions, blood transfusion, or albumin transfusions; use of hemostatic sponges during burn wound management; minimization of blood loss during surgical interventions; timely administration of recombinant erythropoietin in combination with iron preparations; and early use of antihypoxants and antioxidants to prevent erythrocyte hemolysis.

The implementation of this comprehensive approach contributed to a reduction in the incidence of complications associated with burn-related anemia. In the main group, complications were observed in 188 of 570 patients (32.98%). In contrast, in the control group, early and late complications were observed in all 350 patients (100%).

An individualized approach to blood transfusion not only reduced the incidence of complications but also had a significant impact on lowering mortality rates.

Conclusion: Thus, in the treatment of anemia developing in burn disease, an individualized approach based on clinical and laboratory data significantly improved treatment outcomes. It included blood transfusion, plasma transfusion, albumin transfusion, as well as minimization of blood loss.

According to studies conducted over the past 5 years, in 570 patients of the main group, prevention of anemia was initiated from the first day of hospitalization. As a result, the incidence of severe complications (sepsis, multiple organ failure, myocarditis, disseminated intravascular coagulation syndrome, secondary wound deepening, and “burn-related exhaustion”) decreased from 100% to 32.98%. In addition, a significant reduction in mortality rates from burn disease was observed.

1. Dobson GP, Morris JL, Letson HL. Pathophysiology of Severe Burn Injuries: New Therapeutic Opportunities From a Systems Perspective. J Burn Care Res. 2024;45(4):1041-1050. PMID: 38517382. PMCID: PMC11303127. https://doi.org/10.1093/jbcr/irae049

2. Wallace D, Lavrentieva A, Romanowski KS, et al. American Burn Association Clinical Practice Guideline on Blood Product Transfusion in Burn Care. J Burn Care Res. 2025;46(6):1155-1170. PMID: 40720740. https://doi.org/10.1093/jbcr/iraf021

3. Ubushaeva DSh, Sakhin VT, Rukavitsyn OA, et al. Changes in erythrocyte indices as a possible prognostic factor in patients with burn injury. Therapy. 2024;10(S6):321. (In Russ.).

4. Jeschke MG, van Baar ME, Choudhry MA, Chung KK, Gibran NS, Logsetty S. Burn injury. Nat Rev Dis Primers. 2020;6(1):11. PMID: 32054846. PMCID: PMC7224101. https://doi.org/10.1038/s41572-020-0145-5

5. Trauma, Burn, and Critical Care. Journal of the American College of Surgeons. 2024;239(5):S508–57. https://doi.org/10.1097/xcs.0000000000001181

6. Palmieri TL. Transfusion and Infections in the Burn Patient. Surg Infect (Larchmt). 2021;22(1):49-53. PMID: 32559401. https://doi.org/10.1089/sur.2020.160

7. Curinga G, Jain A, Feldman M, Prosciak M, Phillips B, Milner S. Red blood cell transfusion following burn. Burns. 2011;37(5):742-752. PMID: 21367529. https://doi.org/10.1016/j.burns.2011.01.016

8. Zhang W, Zheng Y, Yu K, Gu J. Liberal Transfusion versus Restrictive Transfusion and Outcomes in Critically Ill Adults: A Meta-Analysis. Transfus Med Hemother. 2021;48(1): 60-68. PMID: 33708053. PMCID: PMC7923885. https://doi.org/10.1159/000506751

9. Kaserer A, Rössler J, Slankamenac K, et al. Impact of allogeneic blood transfusions on clinical outcomes in severely burned patients. Burns. 2020;46(5):1083-1090. PMID: 31866181. https://doi.org/10.1016/j.burns.2019.11.005

10. Ivanitsky GR. Blood transfusion: pros, cons, and alternatives. Nauka i Zhizn (Science and Life). 1999;2:14–19. (In Russ.).

11. Souto J, Rodrigues AG. Reducing Blood Loss in a Burn Care Unit: A Review of Its Key Determinants. J Burn Care Res. 2023;44(2):459-466. PMID: 36106386. https://doi.org/10.1093/jbcr/irac114

12. Shander A, Corwin HL, Meier J, et al. Recommendations From the International Consensus Conference on Anemia Management in Surgical Patients (ICCAMS). Ann Surg. 2023;277(4): 581-590. PMID: 36134567. PMCID: PMC9994846. https://doi.org/10.1097/sla.0000000000005721

13. New York State Council on Human Blood and Transfusion Services. Guidelines for transfusion of red blood cells – adults. New York State Department of Health; 2023.

14. Cartotto R, Johnson LS, Savetamal A, et al. American Burn Association Clinical Practice Guidelines on Burn Shock Resuscitation. J Burn Care Res. 2024;45(3):565-589. PMID: 38051821. https://doi.org/10.1093/jbcr/irad125

15. Du Y, Xia Y, You C, et al. Impact of red blood cell transfusion in massive burn: a multicenter cohort study. Sci Rep. 2025;15(1):6196. PMID: 39979424. PMCID: PMC11842838. https://doi.org/10.1038/s41598-025-91052-6

16. Dirjayanto VJ, Anjani JV, Ariviani TP, et al. Restrictive vs liberal blood transfusion strategy for patients with burn trauma: a systematic review and meta-analysis. Br J Hosp Med (Lond). 2023;84(5):1-6. PMID: 37235674. https://doi.org/10.12968/hmed.2023.0144

17. Hu L, Wang B, Jiang Y, et al. Risk Factors for TransfusionRelated Acute Lung Injury. Respir Care. 2021;66(6):1029-1038. PMID: 33774597. https://doi.org/10.4187/respcare.08829

18. Tichil I, Rosenblum S, Paul E, Cleland H. Treatment of Anaemia in Patients with Acute Burn Injury: A Study of Blood Transfusion Practices. J Clin Med. 2021;10(3):476. PMID: 33514060. PMCID: PMC7865424. https://doi.org/10.3390/jcm10030476

19. Lysenko VI, Karpenko EA, Morozova YV. Strategies for perioperative fluid therapy: goal-directed vs liberal and restrictive. Pain, Anesthesia and Intensive Care. 2021;1(94):9–15. https://doi.org/10.25284/2519-2078.1(94).2021.230601

20. Ilinskiy AA, Molchanov IV, Petrova MV. Intraoperative infusion therapy in the perioperative period. Vestnik Rossiiskogo Nauchnogo Tsentra Rentgenoradiologii Minzdrava Rossii. 2012;2(12):6. (In Russ.)

21. Приказ Министра здравоохранения Республики Узбекистан № 402-II от 30.08.2002 года «О донорстве крови и ее компонентов».2002.